Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Nelfinavir Mesylate (Viracept) 是一种口服活性的 HIV-1蛋白酶抑制剂,用于抑制 HIV 感染,是一种广谱抗癌剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 222 | 现货 | ||
5 mg | ¥ 492 | 现货 | ||
10 mg | ¥ 756 | 现货 | ||
25 mg | ¥ 1,580 | 现货 | ||
50 mg | ¥ 2,698 | 现货 | ||
100 mg | ¥ 3,960 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 739 | 现货 |
产品描述 | Nelfinavir Mesylate (Viracept) is an effective HIV protease inhibitor (Ki: 2 nM). |
靶点活性 | HIV protease:2 nM(Ki) |
激酶实验 | GTPγ[35S] binding assay: The cells are homogenized and centrifuged at 26900 × g for 30 min at 4°C. Membranes are re-suspended in 20 mM HEPES (pH 7.4), 100 mM NaCl, 10 mM MgCl2, 1 mM EDTA and 0.1% fat-free BSA at 2–3 mg protein/mL. GTPγ[35S] binding assay is performed with the membranes (75 mg protein /mL in 50 mM HEPES, 100 mM NaCl, 10 mM MgCl2, 20 μg/mL saponin and 0.1% fat-free BSA (pH 7.4), 5 mg/mL with wheat-germ agglutinin-coated scintillation proximity assay-bead, and 10 μM GDP for 10–15 min. The GTPγ[35S]-binding reaction is started by the addition of 200 pM GTPγ[35S]. After 120 min at room temperature, the plates are centrifuged for 10 min at 300 × g and counted. |
别名 | Viracept, Nelfin, AG1343, AG 1343 Mesylate, 甲磺酸奈非那韦 |
分子量 | 663.89 |
分子式 | C33H49N3O7S2 |
CAS No. | 159989-65-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 93 mg/mL (140.1 mM)
Ethanol: 93 mg/mL (140.1 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / Ethanol | 1 mM | 1.5063 mL | 7.5314 mL | 15.0627 mL | 37.6568 mL |
5 mM | 0.3013 mL | 1.5063 mL | 3.0125 mL | 7.5314 mL | |
10 mM | 0.1506 mL | 0.7531 mL | 1.5063 mL | 3.7657 mL | |
20 mM | 0.0753 mL | 0.3766 mL | 0.7531 mL | 1.8828 mL | |
50 mM | 0.0301 mL | 0.1506 mL | 0.3013 mL | 0.7531 mL | |
100 mM | 0.0151 mL | 0.0753 mL | 0.1506 mL | 0.3766 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Nelfinavir Mesylate 159989-65-8 Microbiology/Virology Proteases/Proteasome HIV Protease AG-1343 proliferation Viracept Nelfin HIV protease Nelfinavir AG1343 AG 1343 Mesylate cells infection Human immunodeficiency virus multiple inhibit phosphorylation AG-1343 Mesylate AG 1343 甲磺酸奈非那韦 AG1343 Mesylate Inhibitor production myeloma inhibitor